Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Sleep Apnea01:21

Sleep Apnea

184
Sleep apnea is a condition where breathing stops intermittently during sleep, often leading to significant health issues. Each episode can last from 10 to 20 seconds or more and is frequently accompanied by a brief arousal from sleep. This disturbance, largely unnoticed by the individual, can lead to severe daytime fatigue. Commonly, individuals seek help after being informed by their partners about loud snoring and noticeable breathing pauses during sleep.
The condition is more prevalent among...
184
Management of Insomnia01:19

Management of Insomnia

278
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
278
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

200
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
200
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

440
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
440
Narcolepsy01:07

Narcolepsy

137
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
137
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.6K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Ketogenic Diet in the Treatment of Malignant Gliomas: A Systematic Review.

Nutrients·2026
Same author

Intermittent exposure to high-altitude work: nocturnal hypoxemia sea-level anthropometric and biochemical markers.

Sleep & breathing = Schlaf & Atmung·2026
Same author

Home blood pressure trajectories during 3 months of continuous positive airway pressure therapy in sleepy vs. non-sleepy patients.

Annals of the American Thoracic Society·2026
Same author

Are Women Living With Obesity More Responsive to GLP-1 Receptor Agonists? A Potential Signal From Trial-Level and Within-Trial Analyses.

Diabetes, obesity & metabolism·2026
Same author

Swallowing assessment in spinal muscular atrophy type 1: a real-world study of dysphagia in children receiving disease-modifying therapies.

Neuromuscular disorders : NMD·2026
Same author

Adherence to the Mediterranean diet and its association with atherogenic indices and lipid profile in individuals seeking a weight-loss dietary program: what role for body fat?

Lipids in health and disease·2026

Related Experiment Video

Updated: Jul 17, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.8K

Pharmacotherapy for obstructive sleep apnea: targeting specific pathophysiological traits.

Elisa Perger1, Simona Bertoli1,2,3, Carolina Lombardi1,4

  • 1Sleep Disorders Center & Department of Cardiovascular, Neural and Metabolic Sciences, Istituto Auxologico Italiano, IRCCS, Milan, Italy.

Expert Review of Respiratory Medicine
|August 30, 2023
PubMed
Summary

New pharmacological treatments targeting obstructive sleep apnea (OSA) pathophysiology offer hope. Understanding individual patient traits will enable precision medicine approaches for better sleep disordered breathing management.

Keywords:
CPAPOSA endotypesOSA pharmacotherapyOSA phenotypesPrecision medicineatomoxetinesleep disordered breathing

More Related Videos

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

820
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.3K

Related Experiment Videos

Last Updated: Jul 17, 2025

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea
07:54

Drug-Induced Sleep Endoscopy DISE with Target Controlled Infusion TCI and Bispectral Analysis in Obstructive Sleep Apnea

Published on: December 6, 2016

19.8K
Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach
04:53

Author Spotlight: Traditional Chinese Medicine for Sleep Disorders in Acute COPD — A Safe, Cost-Effective Approach

Published on: October 18, 2024

820
Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders
05:34

Author Spotlight: Utilizing Traditional Chinese Acupuncture of the Ear to Improve Sleep Disorders

Published on: August 18, 2023

2.3K

Area of Science:

  • Sleep Medicine
  • Pharmacology
  • Respiratory Physiology

Background:

  • Obstructive sleep apnea (OSA) pathophysiology is complex and multifactorial.
  • Identified traits include pharyngeal collapsibility, upper airway muscle reactivity, arousal threshold, and ventilatory drive regulation.
  • Current treatments like CPAP have limitations, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To explore novel pharmacological treatments for OSA targeting specific pathophysiological endotypes.
  • To review existing and emerging drugs impacting OSA mechanisms.
  • To summarize promising pharmacotherapies based on their action on key OSA traits.

Main Methods:

  • Literature review of pharmacological agents and their impact on OSA pathophysiology.
  • Analysis of drug mechanisms related to upper airway collapsibility, muscle responsiveness, arousal threshold, and loop gain.
  • Synthesis of evidence for targeted OSA treatment approaches.

Main Results:

  • Several pharmacological drugs show potential by influencing specific OSA endotypes.
  • Drugs can modulate pharyngeal collapsibility, muscle activity, arousal thresholds, and ventilatory control.
  • Combinations of therapies may offer diverse treatment options beyond conventional methods.

Conclusions:

  • Understanding individual OSA pathophysiology is crucial for effective intervention.
  • Pharmacological advancements pave the way for precision medicine in OSA treatment.
  • Future sleep specialists may tailor treatments based on patient-specific disease mechanisms.